Is new always better than old?: The development of human vaccines for anthrax.
about
New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodiesIdentification of peptide sequences as a measure of Anthrax vaccine stability during storage.Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.Use of site-directed mutagenesis to model the effects of spontaneous deamidation on the immunogenicity of Bacillus anthracis protective antigenA single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective Antigen.An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimenThe Use of Germinants to Potentiate the Sensitivity of Bacillus anthracis Spores to Peracetic AcidProgress and novel strategies in vaccine development and treatment of anthrax.The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.Optic Atrophy Secondary to Preseptal Cutaneous Anthrax: Case Report.The role of the exosporium in the environmental distribution of anthrax.Can one size fit all? Towards a universal anthrax vaccine.Bioinspired detoxification of blood: The efficient removal of anthrax toxin protective antigen using an extracorporeal macroporous adsorbent device.
P2860
Q34066161-B805756E-46DF-42B0-AFC9-CF6FF5F458EFQ34121874-B4833254-1D1D-47AE-B53F-DFCE5CBD7D5EQ34290957-177712B5-EA81-4B37-B0B0-62B2F9785C0CQ34344419-912B007F-380F-4BDA-8D9C-11DE3D522FF4Q34433313-DA3776EF-C2B8-4F28-BF87-B22856B823DBQ34463262-6B555E66-8D79-463F-88EB-85E0011232C6Q34700706-ABD85C9F-6F97-4859-8902-51B84A2E2FA1Q35935173-B78A2F33-3CE2-4C3C-8AE6-C5A777A75DBAQ36504794-E3BB9C48-3A6D-4993-946C-01138B0F2B1DQ36516210-1AC3E083-CEC3-4FBB-8526-C667881B9DAFQ37825529-252B7BD5-E678-4ED9-805D-FB4FF40150BDQ39205816-33C29AA4-75C7-448B-B8D7-A426A60467C2Q40199777-BD86B1D5-F7F6-44B0-B250-E25132508D11Q44585272-32A80BBE-A859-4749-AF18-AC50F1BFB9C4Q47250394-A5C7E744-F231-46A2-89BD-A36496EE6633Q54212034-1B6CA892-165F-4BAD-B48B-4612029CDE19
P2860
Is new always better than old?: The development of human vaccines for anthrax.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Is new always better than old?: The development of human vaccines for anthrax.
@ast
Is new always better than old?: The development of human vaccines for anthrax.
@en
type
label
Is new always better than old?: The development of human vaccines for anthrax.
@ast
Is new always better than old?: The development of human vaccines for anthrax.
@en
prefLabel
Is new always better than old?: The development of human vaccines for anthrax.
@ast
Is new always better than old?: The development of human vaccines for anthrax.
@en
P356
P1433
P1476
Is new always better than old?: The development of human vaccines for anthrax
@en
P2093
Leslie W Baillie
P304
P356
10.4161/HV.9777
P50
P577
2009-12-09T00:00:00Z